Global Information
회사소개 | 문의 | 비교리스트

알코올성 간염 치료제 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2020-2030년)

Alcoholic Hepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

리서치사 Transparency Market Research
발행일 2020년 06월 상품 코드 953567
페이지 정보 영문 173 Pages
가격
US $ 5,795 ₩ 6,831,000 PDF (Single User License)
US $ 8,795 ₩ 10,367,000 PDF (Multi-user License)
US $ 11,795 ₩ 13,903,000 PDF (Corporate License)


알코올성 간염 치료제 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2020-2030년) Alcoholic Hepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030
발행일 : 2020년 06월 페이지 정보 : 영문 173 Pages

세계의 알코올성 간염 치료제 시장에 대해 분석했으며, 시장의 기본 구조와 주요 영향요인, 시장 규모 동향 전망(과거 2년간·향후 11년간), 치료법별·용도별·유통 채널별 및 지역별 상세 동향, 경쟁 상황(시장 점유율 구조), 주요 기업 개요 등을 조사했습니다.

목차

제1장 서문

제2장 가정과 조사 방법

제3장 주요 요약

제4장 시장 개요

  • 제품 개요
  • 시장 역학
  • 시장 성장 촉진·억제요인 분석(개요)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 시장 기회
  • 세계의 알코올성 간염 치료제 시장 : 시장 매출 예측
  • 세계의 알코올성 간염 치료제 시장 전망

제5장 시장 전망

  • 세계의 알코올성 간염 치료제 산업에 대한 신종 코로나바이러스 감염증(COVID-19) 감염 확대의 영향
  • 규제 시나리오 : 지역별/세계
  • 의료 개요
  • 파이프라인 분석
  • 알코올성 간질환 역학
  • 알코올성 간염 개요

제6장 세계의 알코올성 간염 치료제 시장 분석 : 치료제별

  • 서론
  • 시장 매출 점유율과 시장 매력 분석 : 치료제별
  • 시장 규모와 예측 : 치료제별
    • 코르티코스테로이드
    • 혈류제
    • 아나볼릭 스테로이드
    • 기타
  • 시장 분석 : 치료제별

제7장 세계의 알코올성 간염 치료제 시장 분석 : 용도별

  • 서론
  • 시장 매출 점유율과 시장 매력 분석 : 용도별
  • 시장 규모와 예측 : 용도별
    • 경도
    • 중도/만성
  • 시장 분석 : 용도별

제8장 세계의 알코올성 간염 치료제 시장 분석 : 유통 채널별

  • 서론
  • 시장 매출 점유율과 시장 매력 분석 : 유통 채널별
  • 시장 규모와 예측 : 유통 채널별
    • 병원 약국
    • 소매 약국
    • 온라인 약국
  • 시장 분석 : 유통 경로별

제9장 세계의 알코올성 간염 치료제 시장 분석 : 지역별

  • 서론
  • 시장 매출 점유율과 시장 매력 분석 : 지역별
  • 시장 규모와 예측 : 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카

제10장 북미의 알코올성 간염 치료제 시장 분석

  • 북미의 알코올성 간염 치료제 시장 분석
  • 시장 매출 점유율과 시장 매력 분석 : 치료제별
  • 시장 예측 : 치료제별
  • 시장 매출 점유율과 시장 매력 분석 : 용도별
  • 시장 예측 : 용도별
  • 시장 매출 점유율과 시장 매력 분석 : 유통 채널별
  • 시장 예측 : 유통 채널별
  • 시장 매출 점유율과 시장 매력 분석 : 국가별
  • 시장 예측 : 국가별
    • 미국
    • 캐나다

제11장 유럽의 알코올성 간염 치료제 시장 분석

제12장 아시아태평양의 알코올성 간염 치료제 시장 분석

제13장 라틴아메리카의 알코올성 간염 치료제 시장 분석

제14장 중동 및 아프리카의 알코올성 간염 치료제 시장 분석

제15장 경쟁 상황

  • 기업 개요
    • Gilead Sciences, Inc.
    • Sanofi
    • Generon Pharmaceutical Technology(Shanghai) Co., Ltd.
    • Immuron Ltd.
    • Intercept Pharmaceuticals, Inc.
KSM 20.08.28

List of Tables

  • Table 01: Alcohol, total per capita (15+) consumption (in liters of pure alcohol) with 95%CI, by Country, 2016
  • Table 02: Epidemiology of Covid-19 Country/Sub-region
  • Table 03: Gross Domestic Product (GDP), by Country, 2014-2017
  • Table 04: Pipeline Analysis of Alcoholic Hepatitis Therapeutics
  • Table 05: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018-2030
  • Table 06: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 07: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 08: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 09: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Treatment, 2018-2030
  • Table 10: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Application, 2018-2030
  • Table 11: North America Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 12: North America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 13: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Treatment, 2018-2030
  • Table 14: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Application, 2018-2030
  • Table 15: Europe Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 16: Europe Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 17: Asia Pacific Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Treatment, 2018-2030
  • Table 18: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 19: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 20: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 21: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018-2030
  • Table 22: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 23: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 24: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 25: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Treatment, 2018-2030
  • Table 26: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 27: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 28: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030

List of Figures

  • Figure 01: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) and Distribution, by Region, 2019 and 2030
  • Figure 02: Global Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 03: Market Value Share, by Treatment, 2019
  • Figure 04: Market Value Share, by Application, 2019
  • Figure 05: Market Value Share, by Distribution Channel, 2019
  • Figure 06: Market Value Share, by Region, 2019
  • Figure 07: Regulatory Approval Process - U.S.
  • Figure 08: Regulatory Approval Process - Europe
  • Figure 09: Regulatory Approval Process - Japan
  • Figure 10: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
  • Figure 11: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020-2030
  • Figure 12: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroids, 2018-2030
  • Figure 13: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hemorrheologic Agents, 2018-2030
  • Figure 14: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anabolic Steroids, 2018-2030
  • Figure 15: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018-2030
  • Figure 16: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 17: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 18: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Mild AH, 2018-2030
  • Figure 19: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Severe/Chronic AH, 2018-2030
  • Figure 20: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 21: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 22: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2030
  • Figure 23: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018-2030
  • Figure 24: Global Alcoholic Hepatitis Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2018-2030
  • Figure 25: Global Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 26: Global Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Region, 2020¬¬-2030
  • Figure 27: North America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 28: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬¬-2030
  • Figure 29: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
  • Figure 30: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬-2030
  • Figure 31: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 32: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬-2030
  • Figure 33: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 34: North America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country, 2019 and 2030
  • Figure 35: North America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 36: Europe Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 37: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬--2030
  • Figure 38: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
  • Figure 39: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬-2030
  • Figure 40: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 41: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬-2030
  • Figure 42: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 43: Europe Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 44: Europe Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 45: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 46: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬¬-2030
  • Figure 47: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
  • Figure 48: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬-2030
  • Figure 49: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 50: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬-2030
  • Figure 51: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 52: Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 53: Asia Pacific Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 54: Latin America Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 55: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬¬-2030
  • Figure 56: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
  • Figure 57: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬-2030
  • Figure 58: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 59: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬-2030
  • Figure 60: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 61: Latin America Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 62: Latin America Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 63 Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 64: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Treatment, 2020¬¬-2030
  • Figure 65: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Treatment, 2019 and 2030
  • Figure 66: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Application, 2020¬¬-2030
  • Figure 67: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 68: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2020¬¬-2030
  • Figure 69: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 70: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 71: Middle East & Africa Alcoholic Hepatitis Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 72: Gilead Sciences, Inc., Revenue (US$ Bn) and Y-o-Y Growth (%), 2016-2019
  • Figure 73: Gilead Sciences, Inc., Breakdown of Net Sales, by Region, 2019
  • Figure 74: Gilead Sciences, Inc., R&D Intensity (%) - Company Level or Segment Level, 2016-2019
  • Figure 75: Sanofi, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 76: Sanofi, Breakdown of Net Sales, by Business Segment, 2019
  • Figure 77: Sanofi, Breakdown of Net Sales, by Region, 2019
  • Figure 78: Immuron, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 79: Immuron, R&D Expenses - Company Level, 2016-2019
  • Figure 80: Intercept Pharmaceuticals, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2019
  • Figure 81: Intercept Pharmaceuticals, Inc., R&D Expenses - Company Level, 2016-2019

Title:
Alcoholic Hepatitis Therapeutics Market (Treatment: Corticosteroids, Hemorrheologic Agents, Anabolic Steroids, and Others; Application: Mild and Severe/Chronic; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030.

Scope of the Report

TMR's report on the global alcoholic hepatitis therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global alcoholic hepatitis therapeutics market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global alcoholic hepatitis therapeutics market from 2020 to 2030.

The report is prepared after an extensive research. Primary research involves bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Extensive secondary research involved reaching out to key players' product literature, annual reports, press releases, and relevant documents to understand the alcoholic hepatitis therapeutics market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the alcoholic hepatitis therapeutics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global alcoholic hepatitis therapeutics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global alcoholic hepatitis therapeutics market.

The report delves into the competition landscape of the global alcoholic hepatitis therapeutics market. Key players operating in the global alcoholic hepatitis therapeutics market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global alcoholic hepatitis therapeutics market profiled in this report.

Key Questions Answered:

  • What is the sales/revenue generated by alcoholic hepatitis therapeutics across all regions during the forecast period?
  • What are the opportunities in the global alcoholic hepatitis therapeutics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which treatment segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Research Objectives and Research Approach

The comprehensive report on the global alcoholic hepatitis therapeutics market begins with an overview, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global alcoholic hepatitis therapeutics market in terms of treatment, application, distribution channel, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global alcoholic hepatitis therapeutics market.

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Research Methodology

3. Executive Summary

  • 3.1. Global Alcoholic Hepatitis Therapeutics Market Snapshot

4. Market Overview

  • 4.1. Product Overview
  • 4.2. Market Dynamics
  • 4.3. Drivers and Restraints Snapshot Analysis
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
    • 4.3.4. Key Trends
  • 4.4. Global Alcoholic Hepatitis Therapeutics Market Revenue Projection
  • 4.5. Global Alcoholic Hepatitis Therapeutics Market Outlook

5. Market Outlook

  • 5.1. COVID-19 Pandemic Impact on Global Alcoholic Hepatitis Therapeutics Industry
  • 5.2. Regulatory Scenario, by Region/globally
  • 5.3. Health Care Overview
  • 5.4. Pipeline Analysis
  • 5.5. Epidemiology of Alcoholic Liver Diseases
  • 5.6. Overview of Alcoholic Hepatitis

6. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Treatment

  • 6.1. Introduction
  • 6.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
  • 6.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
    • 6.3.1. Corticosteroids
    • 6.3.2. Hemorrheologic Agents
    • 6.3.3. Anabolic Steroids
    • 6.3.4. Others
  • 6.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Treatment

7. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Application

  • 7.1. Introduction
  • 7.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
  • 7.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Application
    • 7.3.1. Mild
    • 7.3.2. Severe/Chronic
  • 7.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Application

8. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 8.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Retail Pharmacies
    • 8.3.3. Online Pharmacies
  • 8.4. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Distribution Channel

9. Global Alcoholic Hepatitis Therapeutics Market Analysis, by Region

  • 9.1. Global Alcoholic Hepatitis Therapeutics Market Scenario, by Country
  • 9.2. Global Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Region
  • 9.3. Global Alcoholic Hepatitis Therapeutics Market Forecast, by Region
    • 9.3.1. North America
    • 9.3.2. Europe
    • 9.3.3. Asia Pacific
    • 9.3.4. Latin America
    • 9.3.5. Middle East & Africa

10. North America Alcoholic Hepatitis Therapeutics Market Analysis

  • 10.1. North America Alcoholic Hepatitis Therapeutics Market Analysis
  • 10.2. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
  • 10.3. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
    • 10.3.1. Corticosteroids
    • 10.3.2. Hemorrheologic Agents
    • 10.3.3. Anabolic Steroids
    • 10.3.4. Others
  • 10.4. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
  • 10.5. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Application
    • 10.5.1. Mild
    • 10.5.2. Severe/Chronic
  • 10.6. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 10.7. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
    • 10.7.1. Hospital Pharmacies
    • 10.7.2. Retail Pharmacies
    • 10.7.3. Online Pharmacies
  • 10.8. North America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country
  • 10.9. North America Alcoholic Hepatitis Therapeutics Market Forecast, by Country
    • 10.9.1. U.S.
    • 10.9.2. Canada

11. Europe Alcoholic Hepatitis Therapeutics Market Analysis

  • 11.1. Europe Alcoholic Hepatitis Therapeutics Market Analysis
  • 11.2. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
  • 11.3. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
    • 11.3.1. Corticosteroids
    • 11.3.2. Hemorrheologic Agents
    • 11.3.3. Anabolic Steroids
    • 11.3.4. Others
  • 11.4. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
  • 11.5. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Application
    • 11.5.1. Mild
    • 11.5.2. Severe/Chronic
  • 11.6. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 11.7. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
    • 11.7.1. Hospital Pharmacies
    • 11.7.2. Retail Pharmacies
    • 11.7.3. Online Pharmacies
  • 11.8. Europe Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 11.9. Europe Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
    • 11.9.1. U.K.
    • 11.9.2. Germany
    • 11.9.3. France
    • 11.9.4. Spain
    • 11.9.5. Italy
    • 11.9.6. Rest of Europe

12. Asia Pacific Alcoholic Hepatitis Therapeutics Market Analysis

  • 12.1. Asia Pacific Alcoholic Hepatitis Therapeutics Market Analysis
  • 12.2. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
  • 12.3. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
    • 12.3.1. Corticosteroids
    • 12.3.2. Hemorrheologic Agents
    • 12.3.3. Anabolic Steroids
    • 12.3.4. Others
  • 12.4. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
  • 12.5. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Application
    • 12.5.1. Mild
    • 12.5.2. Severe/Chronic
  • 12.6. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 12.7. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
    • 12.7.1. Hospital Pharmacies
    • 12.7.2. Retail Pharmacies
    • 12.7.3. Online Pharmacies
  • 12.8. Asia Pacific Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 12.9. Asia Pacific Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
    • 12.9.1. Australia & New Zealand
    • 12.9.2. Japan
    • 12.9.3. China
    • 12.9.4. India
    • 12.9.5. Rest of Asia Pacific

13. Latin America Alcoholic Hepatitis Therapeutics Market Analysis

  • 13.1. Latin America Alcoholic Hepatitis Therapeutics Market Analysis
  • 13.2. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
  • 13.3. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
    • 13.3.1. Corticosteroids
    • 13.3.2. Hemorrheologic Agents
    • 13.3.3. Anabolic Steroids
    • 13.3.4. Others
  • 13.4. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
  • 13.5. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Application
    • 13.5.1. Mild
    • 13.5.2. Severe/Chronic
  • 13.6. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 13.7. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
    • 13.7.1. Hospital Pharmacies
    • 13.7.2. Retail Pharmacies
    • 13.7.3. Online Pharmacies
  • 13.8. Latin America Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 13.9. Latin America Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
    • 13.9.1. Brazil
    • 13.9.2. Mexico
    • 13.9.3. Rest of Latin America

14. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Analysis

  • 14.1. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Analysis
  • 14.2. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Treatment
  • 14.3. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Treatment
    • 14.3.1. Corticosteroids
    • 14.3.2. Hemorrheologic Agents
    • 14.3.3. Anabolic Steroids
    • 14.3.4. Others
  • 14.4. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Application
  • 14.5. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Application
    • 14.5.1. Mild
    • 14.5.2. Severe/Chronic
  • 14.6. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Distribution Channel
  • 14.7. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Distribution Channel
    • 14.7.1. Hospital Pharmacies
    • 14.7.2. Retail Pharmacies
    • 14.7.3. Online Pharmacies
  • 14.8. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region
  • 14.9. Middle East & Africa Alcoholic Hepatitis Therapeutics Market Forecast, by Country/Sub-region
    • 14.9.1. GCC Countries
    • 14.9.2. South Africa
    • 14.9.3. Rest of Middle East & Africa

15. Competitive Landscape

  • 15.1. Company Profile
    • 15.1.1. Gilead Sciences, Inc.
      • 15.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.1.1.2. Financial Overview
      • 15.1.1.3. Product Portfolio
      • 15.1.1.4. SWOT Analysis
      • 15.1.1.5. Strategic Overview
    • 15.1.2. Sanofi
      • 15.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.1.2.2. Financial Overview
      • 15.1.2.3. Product Portfolio
      • 15.1.2.4. SWOT Analysis
      • 15.1.2.5. Strategic Overview
    • 15.1.3. Generon Pharmaceutical Technology (Shanghai) Co., Ltd.
      • 15.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.1.3.2. Financial Overview
      • 15.1.3.3. Product Portfolio
      • 15.1.3.4. SWOT Analysis
      • 15.1.3.5. Strategic Overview
    • 15.1.4. Immuron Ltd.
      • 15.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.1.4.2. Product Portfolio
      • 15.1.4.3. SWOT Analysis
      • 15.1.4.4. Strategic Overview
    • 15.1.5. Intercept Pharmaceuticals, Inc.
      • 15.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.1.5.2. Financial Overview
      • 15.1.5.3. Product Portfolio
      • 15.1.5.4. SWOT Analysis
      • 15.1.5.5. Strategic Overview
Back to Top
전화 문의
F A Q